Using SMART Regimens in PM
PHM Session: Get SMART: Implementation of updated asthma guidelines for pediatric hospitalists
Presenters: Alexander Hogan, MD, MS, Connecticut Children’s Medical Center, Hartford, Conn., Kathryn Kyler, MD, MSc, and Claire Seguin, MD, Children’s Mercy Kansas City, Mo.
This session focused on how pediatric hospitalists can improve the asthma care of patients discharged from hospitalizations by instituting single maintenance and reliever therapy (SMART) regimens. More specifically, this is a single inhaler that includes both an inhaled corticosteroid (ICS) and a long-acting beta-agonist (LABA), which have U.S. Food and D...
Source: The Hospitalist - September 23, 2022 Category: Hospital Management Authors: Lisa Casinger Tags: Adolescent Medicine Asthma Clinical Guidelines Pediatrics Source Type: research
Intranasal Olopatadi: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadi: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: Herpes)
Source: Herpes - September 20, 2022 Category: Infectious Diseases Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadi: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis
CONCLUSION: OM significantly improves SAR symptoms and is a viable treatment option in short-term SAR.PMID:36123818 | DOI:10.1177/10600280221124230 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - September 20, 2022 Category: Drugs & Pharmacology Authors: Lauren Lim Melissa Lipari Pramodini Kale-Pradhan Source Type: research
Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis
CONCLUSION: Designing more robust clinical trials may help determine if CSI is a valid treatment option. Until more evidence supporting CSI use exists, health care professionals should strongly consider choosing FDA-approved therapies for the treatment of CRS.PMID:36116748 | DOI:10.1016/j.anai.2022.09.008 (Source: Annals of Allergy, Asthma and Immunology)
Source: Annals of Allergy, Asthma and Immunology - September 18, 2022 Category: Allergy & Immunology Authors: Jonathan A Bernstein Andrew A White Joseph K Han David M Lang David Elkayam Fuad M Baroody Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
